Chartwell Partners is pleased to announce the completion of its fourth C-level recruitment for Encoded Therapeutics, a South San Francisco-based biotechnology company developing precision gene therapies for a broad range of genetic disorders. Speaking of his leadership team, Co-founder and CEO, Kartik Ramamoorthi, Ph.D. stated, “With these appointments, we now have some of the most qualified gene therapy experts in the industry with a proven track record of delivering for patients in need. Their collective experience includes bringing multiple AAV-based gene therapies through clinical development, FDA filings, and approval. I am more confident than ever that our novel gene therapies can make a major impact on patients suffering from debilitating diseases, starting with Dravet Syndrome.”
Dr. Sal Rico joins Encoded as Chief Medical Officer, bringing a wealth of industry experience developing novel therapeutics. Prior to joining Encoded, he served as Senior Vice President of Clinical Development at Audentes Therapeutics, an innovator in neuromuscular gene therapies that was recently acquired by Astellas, Inc. While there, Dr. Rico led the clinical development of AT132, an AAV-based gene therapy for X-Linked Myotubular Myopathy, participated in the design, conduct, and analysis of Phase I-IV clinical trials in multiple therapeutic areas, and successfully contributed to the FDA approval of multiple drugs, biological products, and medical devices including the INTERCEPT Blood System®, Intermezzo®, Hibor®, Champix®, Prolia,® Kerydin®, and others. Prior to joining Audentes, he led the clinical development teams at Cerus Corporation and Transcept Pharmaceuticals and was an investigator at the Centre for Drug Research, Hospital de la Santa Creu i Sant Pau in Barcelona, Spain. Dr. Rico earned his Doctor of Medicine and Surgery degree from the National Autonomous University of Mexico and holds an M.S. and a Ph.D. (Summa Cum Laude) in pharmacology from the Universitat Autonoma de Barcelona. He did his postdoctoral training in clinical pharmacology and transfusion medicine at the National Autonomous University of Mexico, and in pharmaceutical medicine at Universitat Autonoma de Barcelona.
EyeCare Services Partners, a portfolio company of Harvest Partners, has announced the addition of Clint Jaynes, Chief Human Resources Officer, to its leadership team. Clint served earlier in his career as Chief Human Resources Officer for both Solis Mammography & Radiology and Cash America International.
Chartwell Partners is pleased to have recruited this new executive to EyeCare Services Partners.
CareFirst BlueCross BlueShield (CareFirst) has hired Angela Celestin as Executive Vice President and Chief Human Resources Officer, following a nationwide search in partnership with Chartwell Partners. As CareFirst’s top human resources executive, Celestin will be responsible for reshaping the employee experience, enhancing the company’s leadership development programs and leading a strategy to align CareFirst’s workforce with the company’s ambitious short- and long-term goals.
Prior to joining CareFirst, Celestin spent nearly two years as Executive Vice President and Chief Human Resources Officer for National Money Mart Co.’s U.S. and Canadian retail and online lending businesses. She also oversaw the company’s customer contact center in Malvern, PA.
In its 82nd year of service, CareFirst, an independent licensee of the Blue Cross and Blue Shield Association, is a not-for-profit health care company which, through its affiliates and subsidiaries, offers a comprehensive portfolio of health insurance products and administrative services to 3.2 million individuals and groups in Maryland, the District of Columbia and Northern Virginia. In 2018, CareFirst invested $38 million to improve overall health, and increase the accessibility, affordability, safety and quality of health care throughout its market areas.
TPC announced that Roger Nolan has been named its new President and Chief Executive Officer. Mr. Nolan brings more than 30 years of healthcare industry experience through a variety of leadership positions with a focus on strategic planning, operations management and organizational development. He most recently served as a Principal with Vizient in Business Development & Practice Operations. In addition, Mr. Nolan has held senior titles at MedAssets, Broadlane, US Cryotherapy, CMR2 Ventures and LBA Healthcare. Mr. Nolan has extensive knowledge of TPC as he led the MedAssets team that was dedicated to the TPC account during their past partnership. Mr. Nolan’s appointment is the result of an extensive search process conducted by a TPC board-appointed selection committee and Chartwell Partners.
Based in Plano, Texas, TPC is a partnership of community-based hospitals that work together as a single system to aggregate business volume and leverage economies of scale without sacrificing individual independence or local ownership. By working through a committed platform, TPC drives collaboration and innovation across a range of clinical, operational and economic areas enabling providers to maximize the financial and non-financial value they receive. TPC represents 10 health systems and approximately $1 billion in purchasing volume, and has achieved more than $300 million in documented savings since 2010. TPC exists for the sole purpose of helping healthcare organizations remain strong and independent.
Chartwell Partners is pleased to announce that Cindy Kent has joined Brookdale Senior Living as Executive Vice President and President of Senior Living. Ms. Kent has more than 25 years of experience across a variety of roles and segments of the healthcare industry. Most recently, Ms. Kent was president and general manager of 3M’s infection prevention division and a member of the company’s executive conference. She left the position last year after having been with the company for five years.
Brookdale Senior Living Inc. is the leading operator of senior living communities throughout the United States. Brookdale operates and manages independent living, assisted living, memory care, and continuing care retirement communities, with 794 communities in 45 states and the ability to serve approximately 75,000 residents as of September 30, 2019.